In caco-2 cells, most of the "apical" SGLT1 resides in intracellular, 
microtubuli-associated vesicles

Kipp, Helmut; Khoursandi, Saeed; Kinne, Rolf K. H.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Conference Paper

In caco-2 cells, most of the "apical" SGLT1 resides in intracellular, microtubuli-associated vesicles

MPS-Authors

/persons/resource/persons98706

Kipp, Helmut
Sonstige Wissenschaftliche Organisationseinheiten, Max Planck Institute of Molecular Physiology, Max Planck Society;

Khoursandi, Saeed
Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons98705

Kinne, Rolf K. H.
Sonstige Wissenschaftliche Organisationseinheiten, Max Planck Institute of Molecular Physiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Kipp, H., Khoursandi, S., & Kinne, R. K. H. (2002). In caco-2 cells, most of the "apical" SGLT1 resides in intracellular, microtubuli-associated vesicles.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0014-0EBA-A

Abstract

We investigated the distribution of the endogenous sodium/D-glucose cotransporter (SGLT1) in polarized Caco-2 cells, a model for enterocytes. A cellular organelle fraction was separated by free flow electrophoresis. As detected by an ELISA assay the major amount of SGLT1 resides in early endosomal fractions and only a minor amount in apical plasma membranes. The distribution-ratio between endosomes and apical membrane was approximately 2:1. Further immunochemical investigation of SGLT1 distribution by epifluorescence and confocal microscopy revealed that SGLT1 is located in small vesicles associated with microtubuli. Furthermore, the half-life of SGLT1 in Caco-2 cells was determined to be 2.5 d by metabolic labeling followed by immunoprecipitation. Since SGLT1 has a relatively long residence time, it is unlikely that intracellular SGLT1 populations are part of the synthesis/degradation pathway. We, therefore, propose that intracellular compartments containing SGLT1 are part of an endo-/exocytosis process which regulates SGLT1 abundance at the apical cell surface in response to altered physiological demands for D-glucose reabsorption. (This abstract is as it is printed in the journal).